Neuroprotective Role of Transchalcone in Parkinson‘s Disease through AMP-activated Protein Kinase-mediated Signaling Pathway

Neuroprotective Role of Transchalcone in Parkinson‘s Disease through AMP-activated Protein Kinase-mediated Signaling Pathway

Parkinson’s disease (PD) is a gradually worsening neurodegenerative condition marked by the deterioration of dopaminergic neurons, motor dysfunction, and mitochondrial dysfunction. Trans-chalcone, a natural flavonoid, has shown promise in various disease models because of its antioxidant and anti-in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yao Cheng, Shaik Althaf Hussain, Turki Mayudh Alrubie, Xiaomin Zhang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Journal of Physiological Investigation
Subjects:	amp-activated protein kinase cytokines mitochondria neuroprotection parkinson’s disease trans-chalcone
Online Access:	https://journals.lww.com/cjop/fulltext/2024/67060/neuroprotective_role_of_transchalcone_in.3.aspx
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Transchalcone on Neurological Outcomes in Cerebral Ischemia-reperfusion Injury in Rat: Role of AMP-activated Protein Kinase-mitochondrial Signaling Pathways
by: Xiuyun Xue, et al.
Published: (2025-05-01)

New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of Parkinson’s disease
by: Silvana-Yanina Romero-Zerbo, et al.
Published: (2025-01-01)

Neuroprotective role of ranolazine in Parkinson disease: Drosophila melanogaster model
by: Parvesh, et al.
Published: (2025-01-01)

Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models
by: Hongquan Wang, et al.
Published: (2025-02-01)

AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment
by: Nadja I. Lorenz, et al.
Published: (2025-03-01)

Extended Chalcones: Synthesis, In Vitro Analysis, and In Vivo Testing Against a <i>Drosophila melanogaster</i> Alzheimer’s Disease Model
by: Aadya Jaipuria, et al.
Published: (2024-11-01)

Neuroprotective effects of essential oils in animal models of Alzheimer’s and Parkinson’s disease: a systematic review
by: Adrielle do Espírito Santos Macedo, et al.
Published: (2025-07-01)

Redox Regulation of cAMP-Dependent Protein Kinase and Its Role in Health and Disease
by: Ese S. Ekhator, et al.
Published: (2025-04-01)

Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP‐activated protein kinase and autophagy
by: Emilie Dubois‐Deruy, et al.
Published: (2020-06-01)

Neuroprotective role of traditional Chinese plant extracts on Parkinson's disease; a comprehensive preclinical review
by: Rabia Anjum
Published: (2025-03-01)

Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
by: Alicia Bort, et al.
Published: (2019-05-01)

Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review
by: Yu-Hsien Chang
Published: (2025-04-01)

THE PATHOGENETIC ASPECTS OF PARKINSON'S DISEASE AND POSSIBLE WAYS OF THEIR CORRECTION
by: N. M. Buchakchyiska, et al.
Published: (2020-12-01)

Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson’s disease
by: Alexander Shtilbans, et al.
Published: (2024-12-01)

Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action
by: A. M. Mkrtumyan, et al.
Published: (2023-12-01)

Neuroprotective Effects of Ascorbic Acid, Vanillic Acid, and Ferulic Acid in Dopaminergic Neurons of Zebrafish
by: Fatemeh Hedayatikatouli, et al.
Published: (2024-10-01)

A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes
by: François-Xavier Toublet, et al.
Published: (2025-06-01)

The use of Nicotinamide in Parkinson’s disease; A Possible path to the future. Review Article
by: Sarah F Fahmy, et al.
Published: (2023-06-01)

Regulation of autophagy-related gene expressions by Trans-chalcone in the lungs of adult male rats
by: Fatemeh Salehi Mazdeh, et al.
Published: (2025-04-01)

Isolation and Characterization of Earthworm Peptides with Neuroprotective Effects in Parkinson’s Disease Models
by: Guangyu Shi, et al.
Published: (2025-04-01)

Unveiling the intricacies: small interfering RNA targeting Snail-1 unravels dynamics in endometrial carcinoma cell behavior
by: Feng Li, et al.
Published: (2025-06-01)

Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
by: Enzo Pereira de Lima, et al.
Published: (2025-02-01)

Predicting the effectiveness of methotrexate therapy based on basal expression of the AMP-activated protein kinase gene in the blood of patients with rheumatoid arthritis
by: E. V. Chetina, et al.
Published: (2022-02-01)

Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Carvacrol Essential Oil as a Neuroprotective Agent: A Review of the Study Designs and Recent Advances
by: Fahad Khan Tareen, et al.
Published: (2024-12-01)

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis
by: Gabriel C. Barsotti, et al.
Published: (2024-05-01)

Correction: Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Neuroprotective effects of melanins and melanin derivatives from Calvatia Craniiformis and Xylaria plebeja against Parkinsonian toxins
by: Duong Thuy Nguyen, et al.
Published: (2025-02-01)

Inhibition of protein kinase D and its substrate phosphatidylinositol-4 kinase III beta blocks common human coronavirus replication
by: Huijuan Han, et al.
Published: (2024-12-01)

Thiacalix[4]arene chalcone amides effect on myometrium contraction
by: O. V. Tsymbalyuk, et al.
Published: (2024-08-01)

Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases
by: Fengjiao Wang, et al.
Published: (2025-04-01)

Mitotherapy attenuates sepsis-induced brain injury in rats subjected to cecal ligation and puncture: Role of SIRT-1/PGC-1α network
by: Behnaz Mokhtari, et al.
Published: (2025-08-01)

Mechanical peripheral stimulation for the treatment of gait disorders in patients with Parkinson’s disease: a multi-centre, double-blind, crossover randomized controlled trial
by: Maria Francesca De Pandis, et al.
Published: (2025-04-01)

Target oxidative stress-induced disulfidptosis: novel therapeutic avenues in Parkinson’s disease
by: Junshi Zhang, et al.
Published: (2025-04-01)

Intervention strategies for Parkinson’s disease: the role of exercise and mitochondria
by: Ganggang Xu, et al.
Published: (2025-05-01)

2024 international conference on neuroprotective agents conference proceedings
by: William Slikker, et al.
Published: (2025-07-01)

Exploring the correlation between Drp1 protein and the neurotoxicity of propofol
by: Pu Guo, et al.
Published: (2025-07-01)

Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke
by: Chun Li, et al.
Published: (2026-03-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Carveol, a natural monoterpene from essential oils prevents neuronal impairments associated with murine Parkinson's disease model in rats
by: Ola A. Habotta, et al.
Published: (2025-08-01)